Optimi Health Corp. filed a Form F-1 with the U.S. Securities and Exchange Commission on August 17, 2026. The filing registers up to 21,943,260 common shares for resale by current investors.
Optimi Health will not receive any proceeds from this secondary offering. The move provides a mechanism for nearly 22 million shares to enter the public market.
Investors are monitoring the filing for potential downward pressure on the stock price. Increased market supply often impacts share valuation during large secondary offerings.